TP53 was one of the two genes with a significant consistent trend in mutation prevalence towards malignancy, while four other genes (HNF1A, KAT6B, FBXW7, and NFKB1) exhibited the opposite trend, with mutation frequencies decreasing towards carcinoma. This evidence concerns the gene NFKB1 and carcinoma.